Dashboard
Manage Tickers

IMNN Imunon, Inc.

Nasdaq imunon.com


$ 4.24 $ 0.00 (0 %)    

Friday, 14-Nov-2025 04:40:17 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 600.35 $ 0.00 (0 %)
DIA $ 471.82 $ 0.00 (0 %)
SPY $ 666.05 $ 0.00 (0 %)
TLT $ 89.73 $ 0.00 (0 %)
GLD $ 373.13 $ 0.00 (0 %)
$ 4.16
$ 3.87
$ 4.07 x 2
$ 4.12 x 100
-- - --
$ 3.64 - $ 41.22
92,812
na
12.77M
$ 0.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 02-27-2025 01-01-1970 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-28-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-30-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-15-2022 06-30-2022 10-Q
15 05-16-2022 03-31-2022 10-Q
16 03-31-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-14-2021 03-31-2021 10-Q
20 03-19-2021 12-31-2020 10-K
21 11-16-2020 09-30-2020 10-Q
22 08-14-2020 06-30-2020 10-Q
23 05-15-2020 03-31-2020 10-Q
24 03-25-2020 12-31-2019 10-K
25 11-14-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 03-29-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 08-14-2018 06-30-2018 10-Q
31 05-11-2018 03-31-2018 10-Q
32 03-27-2018 12-31-2017 10-K
33 11-14-2017 09-30-2017 10-Q
34 08-14-2017 06-30-2017 10-Q
35 05-12-2017 03-31-2017 10-Q
36 03-24-2017 12-31-2016 10-K
37 11-10-2016 09-30-2016 10-Q
38 08-15-2016 06-30-2016 10-Q
39 05-16-2016 03-31-2016 10-Q
40 03-30-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

imunon-q3-eps-116-beats-180-estimate
Imunon Q3 EPS $(1.16) Beats $(1.80) Estimate
11/13/2025 12:46:39

earnings-scheduled-for-november-13-2025
Earnings Scheduled For November 13, 2025
11/13/2025 11:11:32

exploring-imunons-earnings-expectations
Exploring Imunon's Earnings Expectations
11/12/2025 17:03:46

imunon-updates-on-final-phase-3-trial-for-its-dna-based-ovarian-cancer-therapy
IMUNON Updates on Final Phase 3 Trial for ...
11/10/2025 12:44:44

IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today is prese...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
11/10/2025 12:06:58

imunon-to-present-data-from-its-phase-3-ovation-3-trial-and-phase-2-minimal-residual-disease-trial-on-nov-10-at-rd-day
IMUNON To Present Data From Its Phase 3 OV...
11/04/2025 13:13:30

IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announce...

imunon-to-present-ongoing-phase-3-ovation-3-clinical-trial-of-imnn-001-at-igcs-2025-annual-global-meeting
IMUNON To Present Ongoing Phase 3 OVATION ...
10/30/2025 12:07:09

Trials-in-progress poster of ongoing pivotal Phase 3 trial of DNA-mediated immunotherapy accepted at both IGCS and ESMO Congres...

imunon-to-present-new-translational-data-from-phase-2-ovation-2-clinical-trial-of-imnn-001-investigational-therapy-for-ovarian-cancer-at-sitc-40th-annual-meeting
IMUNON To Present New Translational Data F...
10/23/2025 14:12:46

IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per planLAWRENCEVILLE, N.J., Oct. 23, 2025 (GLOBE N...

imunon-to-host-investor-rd-day-on-november-10-2025-to-present-phase-3-imnn-001-ovarian-cancer-study-updates
IMUNON To Host Investor R&D Day On Novembe...
10/20/2025 12:06:44

Investor event to provide update on pivotal Phase 3 study of IMNN-001 to be held in New York City on November 10, 2025Program w...

reported-earlier-imunon-to-give-oral-presentations-highlighting-imnn-101-its-investigational-dna-plasmid-vaccine-based-on-the-companys-proprietary-placcine-technology-platform-at-leading-vaccine-conferences
Reported Earlier: Imunon To Give Oral Pres...
10/17/2025 15:41:37

LAWRENCEVILLE, N.J., Oct. 17, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company focused on developi...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/15/2025 21:07:03

imunon-to-present-phase-3-ovation-3-clinical-trial-imnn-001-at-esmo-congress
IMUNON To Present Phase 3 OVATION 3 Clinic...
10/14/2025 12:21:05

Prestigious European Society for Medical Oncology Conference "trials-in-progress" sessionPivotal OVATION 3 trial of its...

imunon-presents-imnn-001-phase-2-translational-data-in-ovarian-cancer-results-showed-13-month-increase-in-overall-survival
IMUNON Presents IMNN-001 Phase 2 Translati...
09/22/2025 12:06:58

imunon-to-present-new-translational-data-from-phase-2-ovation-2-study-of-imnn-001-at-2025-aacr-special-conference-in-cancer-research
IMUNON To Present New Translational Data F...
09/19/2025 12:07:43

OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treatedLAWRENCEVILLE, N.J., Sept. ...

imunon-regains-nasdaq-compliance
IMUNON Regains Nasdaq Compliance
08/28/2025 12:08:30

imunon-q2-2025-eps-215-may-not-be-comparable-to-034-estimate-cash-and-cash-equivalents-were-47m-expected-to-provide-cash-runway-into-q4-2025
Imunon Q2 2025 EPS $(2.15) May Not Be Comp...
08/05/2025 12:04:47

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

insights-into-imunons-upcoming-earnings
Insights into Imunon's Upcoming Earnings
08/04/2025 21:03:29

imunon-imnn-stock-is-trending-wednesday-whats-going-on
IMUNON (IMNN) Stock Is Trending Wednesday:...
07/30/2025 15:48:30

Shares of IMUNON are trading higher Wednesday morning. The company announced a clinical milestone for its lead drug candidate, ...

imunon-doses-first-patient-in-phase-3-ovation-3-study-of-imnn-001-for-ovarian-cancer
IMUNON Doses First Patient In Phase 3 OVAT...
07/30/2025 12:07:53

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION